Error: Could not add to watchlist. X
+ Watchlist

Credit Suisse Lux Global Biotech Innovators Equity Fund

CLABIOT:LX
451.11
USD
6.91
1.56%
As of 11/16/2017
Fund Type
SICAV
52Wk Range
359.99 - 479.42
1 Yr Return
15.73%
YTD Return
25.31%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
444.20
52Wk Range
359.99 - 479.42
1 Yr Return
15.34%
YTD Return
25.31%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 11/16/2017)
451.11
Total Assets (m USD) (on 11/16/2017)
159.552
Inception Date
10/05/2001
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
THOMAS AMREIN
Front Load Fee
5.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.92%
Expense Ratio
2.19%

Top Fund Holdings

Name Position Value % of Fund
97.00 k 14.14 m 8.10
20.40 k 9.12 m 5.23
110.00 k 8.91 m 5.11
67.00 k 7.82 m 4.48
50.50 k 7.68 m 4.40
34.00 k 6.34 m 3.63
18.70 k 5.86 m 3.35
61.50 k 5.72 m 3.28
39.00 k 5.47 m 3.13
25.50 k 5.08 m 2.91
Profile
Credit Suisse Lux Global Biotech Innovators Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.
Address
Credit Suisse AG
Kalanderplatz 1
8070 Zurich
Switzerland
Tel: +41 44 333 40 50
Phone
-